Module 2 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Visit https://annenberg.net/Atopic-Dermatit... to download resources, view more videos and earn CME credit. Lawrence F. Eichenfield, MD, and Jonathan Silverberg, MD, PhD, MPH, provide their perspectives on the clinical impact of 6 recently published studies involving the management of patients with atopic dermatitis. This module discusses "Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults" by Dr. Paller and colleagues. The study results appeared in the September 2016 issue of the Journal of the American Academy of Dermatology.

Module 2 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Module 4 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Module 5 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Module 3 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Module 6 - Expert Analysis of Emerging Atopic Dermatitis Therapy Studies

Medical Management (2 of 3) - Emerging Treatments in Moderate to Severe Atopic Dermatitis

Epidemiology - Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis

Emerging Therapies - Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis

The New Paradigm in Atopic Dermatitis Treatment: Line 7 Stop 8 Summary

Clinical update on the treatment of atopic dermatitis: SOLO 1 and SOLO 2 dupilumab Phase 3 data

[INT-ISC-EK] What do you think are the most important parts of eczema therapy you should know?

IMEF 2022: The challenge of the training and the consensus - Lawrence Eichenfield

The New Paradigm in Atopic Dermatitis Treatment: Line 5 Stop 1 Poor Adherence

Medical Management (3 of 3) - Emerging Treatments in Moderate to Severe Atopic Dermatitis

Atopic Dermatitis: Cost and Value

Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies

Treatment of Moderate-Severe Atopic Dermatitis: LIne 7 Stop 5 Summary

Nonsteroidal topical expands options for pediatric AD

Treatment of Moderate-Severe Atopic Dermatitis: Overview

The Future of Atopic Dermatitis